| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |